Paul Sekhri Recruited as Exec Chair to Laverock Therapeutics by Occam Global
In November 2026, Occam Global recruited Paul Sekhri as Executive Chairman of Laverock Therapeutics, a UK biotechnology company whose gene-control platform is designed to improve the performance of CAR-T therapies in solid tumors.
Paul brings nearly four decades of life sciences leadership and has served on more than 40 public and private company boards. As Chairman of Longboard Pharmaceuticals, he oversaw its $2.6 billion sale to Lundbeck in December 2024. He is currently Chairman, President, and CEO of vTv Therapeutics and previously served as President and CEO of eGenesis, where he raised $400 million.

View recent Placements



.jpg)
DISCOVER OCCAM GLOBAL
Occam Global is a leading executive search and advisory partner for entrepreneurs, investors, and corporations targeting exceptional goals across the life sciences, deep tech, and venture capital sectors worldwide. Since 2012, Occam has collaborated with top founders, CEOs, and investors across the tech industry to provide high-performing leaders who fuel growth. From stealth startups to public markets, we recruit senior executives, advise on organizational strategies, and invest alongside visionary teams to build innovative companies.
Occam’s success is rooted in our proven ability to attract outstanding business and scientific leaders, seamless access to rare talent, and a strong commitment to results guided by high ethics and enlightened aggression. Whether you’re launching, leading, or investing, we are here to support growth through the power of talent.